SNYR
Price
$2.07
Change
+$0.31 (+17.61%)
Updated
Jun 3 closing price
Capitalization
494.39K
ZYXI
Price
$2.14
Change
+$0.12 (+5.94%)
Updated
Jun 3 closing price
Capitalization
397.95M
50 days until earnings call
Interact to see
Advertisement

SNYR vs ZYXI

Header iconSNYR vs ZYXI Comparison
Open Charts SNYR vs ZYXIBanner chart's image
Synergy CHC
Price$2.07
Change+$0.31 (+17.61%)
Volume$218.94K
Capitalization494.39K
Zynex
Price$2.14
Change+$0.12 (+5.94%)
Volume$676.24K
Capitalization397.95M
SNYR vs ZYXI Comparison Chart
Loading...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNYR vs. ZYXI commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNYR is a Hold and ZYXI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (SNYR: $2.07 vs. ZYXI: $2.14)
Brand notoriety: SNYR and ZYXI are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: SNYR: 14% vs. ZYXI: 287%
Market capitalization -- SNYR: $494.39K vs. ZYXI: $397.95M
SNYR [@Medical Distributors] is valued at $494.39K. ZYXI’s [@Medical Distributors] market capitalization is $397.95M. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNYR’s FA Score shows that 0 FA rating(s) are green whileZYXI’s FA Score has 0 green FA rating(s).

  • SNYR’s FA Score: 0 green, 5 red.
  • ZYXI’s FA Score: 0 green, 5 red.
According to our system of comparison, SNYR is a better buy in the long-term than ZYXI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNYR’s TA Score shows that 2 TA indicator(s) are bullish while ZYXI’s TA Score has 4 bullish TA indicator(s).

  • SNYR’s TA Score: 2 bullish, 4 bearish.
  • ZYXI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ZYXI is a better buy in the short-term than SNYR.

Price Growth

SNYR (@Medical Distributors) experienced а +16.29% price change this week, while ZYXI (@Medical Distributors) price change was -17.37% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -1.95%. For the same industry, the average monthly price growth was -0.63%, and the average quarterly price growth was -4.99%.

Reported Earning Dates

SNYR is expected to report earnings on Mar 31, 2025.

ZYXI is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Medical Distributors (-1.95% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZYXI($398M) has a higher market cap than SNYR($494K). SNYR YTD gains are higher at: -52.955 vs. ZYXI (-73.283). ZYXI has higher annual earnings (EBITDA): 17.9M vs. SNYR (-8.26M). ZYXI has more cash in the bank: 44.6M vs. SNYR (315K). SNYR has less debt than ZYXI: SNYR (5.8M) vs ZYXI (76.2M). ZYXI has higher revenues than SNYR: ZYXI (184M) vs SNYR (26M).
SNYRZYXISNYR / ZYXI
Capitalization494K398M0%
EBITDA-8.26M17.9M-46%
Gain YTD-52.955-73.28372%
P/E RatioN/A46.30-
Revenue26M184M14%
Total Cash315K44.6M1%
Total Debt5.8M76.2M8%
FUNDAMENTALS RATINGS
SNYR vs ZYXI: Fundamental Ratings
SNYR
ZYXI
OUTLOOK RATING
1..100
729
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
85100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3465
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5031

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNYR's Valuation (56) in the null industry is somewhat better than the same rating for ZYXI (93) in the Medical Specialties industry. This means that SNYR’s stock grew somewhat faster than ZYXI’s over the last 12 months.

SNYR's Profit vs Risk Rating (85) in the null industry is in the same range as ZYXI (100) in the Medical Specialties industry. This means that SNYR’s stock grew similarly to ZYXI’s over the last 12 months.

SNYR's SMR Rating (100) in the null industry is in the same range as ZYXI (100) in the Medical Specialties industry. This means that SNYR’s stock grew similarly to ZYXI’s over the last 12 months.

SNYR's Price Growth Rating (34) in the null industry is in the same range as ZYXI (65) in the Medical Specialties industry. This means that SNYR’s stock grew similarly to ZYXI’s over the last 12 months.

SNYR's P/E Growth Rating (100) in the null industry is in the same range as ZYXI (100) in the Medical Specialties industry. This means that SNYR’s stock grew similarly to ZYXI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNYRZYXI
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
54%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 19 days ago
70%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDECX21.61N/A
N/A
Fidelity Advisor Capital Development C
FGEAX25.24N/A
N/A
Fidelity Advisor Glbl Capital Apprec A
CAFRX9.23N/A
N/A
Commonwealth Africa
PHLQX40.92N/A
N/A
PGIM Jennison Health Sciences R6
SIVIX16.14N/A
N/A
State Street Instl Small-Cap Equity Inv

SNYR and

Correlation & Price change

A.I.dvisor tells us that SNYR and COSM have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYR and COSM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYR
1D Price
Change %
SNYR100%
+17.61%
COSM - SNYR
17%
Poorly correlated
-0.22%
ZYXI - SNYR
-1%
Poorly correlated
+5.94%
CAH - SNYR
-3%
Poorly correlated
+0.15%
HSIC - SNYR
-7%
Poorly correlated
+1.45%
MCK - SNYR
-7%
Poorly correlated
-0.95%
More

ZYXI and

Correlation & Price change

A.I.dvisor tells us that ZYXI and HSIC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZYXI and HSIC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZYXI
1D Price
Change %
ZYXI100%
+5.94%
HSIC - ZYXI
26%
Poorly correlated
+1.45%
OMI - ZYXI
16%
Poorly correlated
+5.35%
GEG - ZYXI
11%
Poorly correlated
-0.47%
AMFPF - ZYXI
10%
Poorly correlated
N/A
EDAP - ZYXI
9%
Poorly correlated
-0.97%
More